Dicyclohexylcarbodiimide → HCID 86761365, compound
Reaction equation
[Si:1]([O:8][C@@H:9]1[C@@:32]2([CH3:33])[C:13](=[CH:14][CH:15]=[C:16]3[C@@H:31]2[CH2:30][CH2:29][C@@:28]2([CH3:34])[C@H:17]3[CH2:18][CH2:19][C@@H:20]2[C@@H:21]([O:23][CH2:24][C:25]([OH:27])=[O:26])[CH3:22])[CH2:12][C@@H:11]([O:35][Si:36]([C:39]([CH3:42])([CH3:41])[CH3:40])([CH3:38])[CH3:37])[CH2:10]1)([C:4]([CH3:7])([CH3:6])[CH3:5])([CH3:3])[CH3:2].[CH3:43][CH2:44][CH:45](O)[CH2:46][CH3:47].C1(N=C=NC2CCCCC2)CCCCC1>CN(C)C1C=CN=CC=1.ClCCl>[Si:1]([O:8][C@@H:9]1[C@@:32]2([CH3:33])[C:13](=[CH:14][CH:15]=[C:16]3[C@@H:31]2[CH2:30][CH2:29][C@@:28]2([CH3:34])[C@H:17]3[CH2:18][CH2:19][C@@H:20]2[C@@H:21]([O:23][CH2:24][C:25]([O:27][CH:45]([CH2:46][CH3:47])[CH2:44][CH3:43])=[O:26])[CH3:22])[CH2:12][C@@H:11]([O:35][Si:36]([C:39]([CH3:41])([CH3:40])[CH3:42])([CH3:37])[CH3:38])[CH2:10]1)([C:4]([CH3:7])([CH3:6])[CH3:5])([CH3:3])[CH3:2]Participants
6
Procedure
[{1α,3β-Bis(tert-butyldimethylsilyloxy)pregna-5,7-dien-20(S)-yl}oxy]acetic acid (91 mg, 0.147 mmol) was treated with 3-pentanol (39 mg, 0.443 mmol), N,N′-dicyclohexylcarbodiimide (61 mg, 0.296 mmol) and 4-(dimethylamino)pyridine (54 mg, 0.443 mmol) in dichloromethane (1.5 ml) in the same manner as shown in Example 17(3) (at room temperature for 15 hours), followed by work up and purification using preparative thin layer chromatography (0.5 mm×3 plates, hexane:ethyl acetate=5:1, developed once) to give the titled compound (37 mg, 37%) as a colorless oil.
Workup
- customas shown in Example 17(3) (at room temperature for 15 hours)
- custompurification
Sources & evidence
- ORD record
- ord-b118c2ada1f94fbe8ae910cf524d63eb
- Source dataset
- uspto-grants-2011_07
- Patent number
- US07985744B2
Reaction notes
Loading…